Impact of Rosuvastatin Doses on LDL Levels, CPK Levels and Aspartate Aminotransferase Levels

NCT ID: NCT06910098 Phase: NA Status: COMPLETED Enrollment: 195 Completion: 2024-08-31

Conditions

LDL - Low Density Lipoprotein Receptor Disorder, Rosuvastatin

Interventions

Rosuvastatin, Rosuvastatin, Rosuvastatin

Summary

Particpants were divided into groups based on doses of rosuvastatin and were assessed and for CPK, LDL and AST levels

Primary Outcome

impact of rosuvstatin over LDL, CPK and AST levels

Source

ClinicalTrials.gov